VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $202,000 | -30.8% | 12,683 | -9.7% | 0.02% | -31.8% |
| Q4 2017 | $292,000 | +33.9% | 14,050 | -7.7% | 0.02% | +22.2% |
| Q3 2017 | $218,000 | -23.2% | 15,230 | -7.2% | 0.02% | -33.3% |
| Q2 2017 | $284,000 | +54.3% | 16,414 | -1.5% | 0.03% | +50.0% |
| Q1 2017 | $184,000 | -30.0% | 16,656 | +55.4% | 0.02% | -41.9% |
| Q3 2016 | $263,000 | +8.2% | 10,718 | +685.2% | 0.03% | -18.4% |
| Q3 2015 | $243,000 | -37.5% | 1,365 | -22.0% | 0.04% | -29.6% |
| Q2 2015 | $389,000 | +54.4% | 1,749 | +37.8% | 0.05% | +63.6% |
| Q1 2015 | $252,000 | – | 1,269 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |